GDUFA Research Outcomes
Mixture APIs
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to complex active pharmaceutical ingredients that are comprised of a mixtures (e.g., polymers) in generic products.
-
Identification and Quantitation of Host Cell Protein Impurities in Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry
Wang, Xiaoshi
-
Scientific Considerations for the Assessment Immunogenicity Risk of Generic Synthetic Peptide Products
Verthelyi, Daniela
-
In Vitro Binding Studies for Bioequivalence Demonstration
Sun, Wei-Jhe
-
Comparative Characterization of Highly Heterogeneous Drugs
Sasisekharan, Ram
-
Guidance for Peptide Products and Assessing Immunogenicity Risk
Pang, Eric
-
Non-clinical Evaluation of Comparative Immunogenicity Risk of Complex Peptide Products
Pang, Eric
-
Overview: Non-clinical Immunogenicity Assessment of Generic Peptide Products
Pang, Eric; Vertheryi, Daniela
-
Scientific and Regulatory Considerations for Synthetic Peptides Referencing Peptide Drug Products of rDNA Origin
Pang, Eric
-
Resolving Peptide Drug Challenges Through Pre-ANDA Processes
Pang, Eric
-
Introductory Remarks
Lionberger, Robert